APA (7th ed.) Citation

Synn, C., Kim, S. E., Lee, H. K., Kim, M., Kim, J. H., Lee, J. M., . . . Choi, H. (2022). SKI‐G‐801, an AXL kinase inhibitor, blocks metastasis through inducing anti‐tumor immune responses and potentiates anti‐PD‐1 therapy in mouse cancer models. Clinical & Translational Immunology, 11(1), 1. https://doi.org/10.1002/cti2.1364

Chicago Style (17th ed.) Citation

Synn, Chun‐Bong, et al. "SKI‐G‐801, an AXL Kinase Inhibitor, Blocks Metastasis Through Inducing Anti‐tumor Immune Responses and Potentiates Anti‐PD‐1 Therapy in Mouse Cancer Models." Clinical & Translational Immunology 11, no. 1 (2022): 1. https://doi.org/10.1002/cti2.1364.

MLA (9th ed.) Citation

Synn, Chun‐Bong, et al. "SKI‐G‐801, an AXL Kinase Inhibitor, Blocks Metastasis Through Inducing Anti‐tumor Immune Responses and Potentiates Anti‐PD‐1 Therapy in Mouse Cancer Models." Clinical & Translational Immunology, vol. 11, no. 1, 2022, p. 1, https://doi.org/10.1002/cti2.1364.